Haisco Pharmaceutical Group Co., Ltd.
Clinical trials sponsored by Haisco Pharmaceutical Group Co., Ltd., explained in plain language.
-
New pill shows promise against fatty liver disease in early trial
Disease control CompletedThis study tested an experimental drug called HSK31679 in 186 Chinese adults with non-alcoholic steatohepatitis (NASH), a serious fatty liver disease with scarring. Participants took either 80 mg, 160 mg, or a placebo daily for 52 weeks. The main goal was to see if the drug could…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:43 UTC
-
New COPD inhaler shows promise in large trial
Disease control CompletedThis study tested a new inhaled medicine called HL231 in 487 Chinese adults with moderate to very severe COPD. The goal was to see if HL231 works better than an existing inhaler (Ultibro) at improving lung function and reducing flare-ups over 26 to 52 weeks. Participants used the…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:24 UTC
-
New pill aims to slow lung scarring in IPF patients
Disease control CompletedThis study tested a new tablet called HSK44459 in 186 adults aged 40 and older with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. The goal was to see if the drug could improve lung function over 12 weeks compared to a placebo. Resea…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New PNH pill shows promise in Head-to-Head trial
Disease control CompletedThis study tested a new tablet called HSK39297 against the standard drug eculizumab in 73 adults with paroxysmal nocturnal hemoglobinuria (PNH) who had never taken complement inhibitors. The goal was to see if the new pill could raise hemoglobin levels and reduce the need for blo…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New pill offers hope for PNH patients with persistent anemia
Disease control CompletedThis study tested a new pill, HSK39297, in 36 adults with paroxysmal nocturnal hemoglobinuria (PNH) who still had anemia despite standard treatment. The goal was to see if the pill could raise hemoglobin levels and reduce the need for blood transfusions. The trial is now complete…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
New pain shot could replace morphine after surgery?
Symptom relief CompletedThis study tested a new medicine called HSK21542 to see if it can safely reduce pain after hip replacement surgery. About 160 adults were randomly assigned to receive HSK21542, morphine, or a placebo. The main goal was to measure how well each treatment lowered pain intensity ove…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated May 17, 2026 02:40 UTC
-
New nerve pain drug shows promise in Year-Long trial
Symptom relief CompletedThis study tested the long-term safety and effectiveness of HSK16149 capsules in 301 Chinese patients with peripheral neuralgia (nerve pain) over 52 weeks. Participants had previously completed a shorter study of the same drug. Researchers monitored side effects, lab results, and…
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated May 08, 2026 12:01 UTC
-
Healthy volunteers test new Drug's reaction to food
Knowledge-focused CompletedThis study looked at how taking a new drug called HSK47388 with or without food changes the way the body processes it. Fifteen healthy adults took the drug at different times relative to meals. The goal was to understand the drug's safety and how it moves through the body, not to…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 17, 2026 02:43 UTC
-
Generic Parkinson's drug passes first test in healthy volunteers
Knowledge-focused CompletedThis study tested whether a new generic version of pramipexole extended-release tablets works the same as the brand-name drug (MIRAPEX ER). It involved 49 healthy Chinese adults who took a single dose of each version under fasting and fed conditions. The goal was to check if the …
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC
-
Generic numbing cream matches brand in healthy volunteer study
Knowledge-focused CompletedThis study tested whether a generic lidocaine and prilocaine cream works the same as the brand-name EMLA® cream. Forty healthy adults received a single dose of each cream on separate days. Researchers measured drug levels in the blood and checked for side effects to see if the ge…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC
-
Generic HIV drug matches brand in healthy volunteer study
Knowledge-focused CompletedThis study checked if a generic version of tenofovir disoproxil fumarate (a drug used for HIV and hepatitis B) works the same as the brand-name drug Viread. 47 healthy Chinese adults took both versions under fasting and fed conditions. The goal was to see if the generic is safe a…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC